Neuromodulation Market

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

Report Code: BT 3571 Jul, 2015, by marketsandmarkets.com

The neuromodulation market is segmented on the basis of technology, application, and region. The global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020, to reach $6.20 Billion by 2020 from $3.65 Billion in 2015. Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players, and expanded target applications and new indications are driving the growth of this market. Moreover, expansion in emerging economies is likely to create significant growth opportunities for players operating in the neuromodulation market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals act as restraints hindering its market growth.

Some of the major players in the global neuromodulation market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel).

Scope of the Report:

This research report categorizes the neuromodulation market into the following segments and sub-segments:

Neuromodulation Market, by Technology

  • Internal Neuromodulation
    • Spinal Cord Stimulation
    • Deep Brain Stimulation
    • Vagus Nerve Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation
  • External Neuromodulation
    • Transcutaneous Electrical Nerve Stimulation
    • Transcranial Magnetic Stimulation
    • Respiratory Electrical Stimulation

Neuromodulation Market, by Application

  • Spinal Cord Stimulation
    • Chronic Pain
    • Failed Back Surgery
    • Ischemia
  • Deep Brain Stimulation
    • Parkinson's disease
    • Tremor
    • Depression
    • Others ( Alzheimer's disease, Dystonia, Tourette syndrome)
  • Sacral Nerve Stimulation
    • Urine Incontinence
    • Fecal Incontinence
  • Vagus Nerve Stimulation Market
    • Epilepsy

Others (Heart failure, Tinnitus)

  • Gastric Electrical Stimulation
    • Gastroparesis
    • Obesity
  • Transcranial Magnetic Stimulation
    • Depression
    • Migraine headaches
  • Transcutaneous Electrical Nerve Stimulation
    • Treatment Resistant Depression
    • Others ( Stroke, Tinnitus)

Neuromodulation Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe (RoE)
  • Asia
    • China
    • Japan
    • India
    • Rest of Asia (RoA)
  • Rest of the World (RoW)

Neuromodulation is a technique that acts directly on nerves or the target area, where the activity of nerves is altered. These alterations are due to the effects produced by electrical stimulation or drug infusion. These devices include small electrodes, which are placed in the brain, spinal cord, or peripheral nerves, and are connected via leads to an implantable pulse generator placed under the skin to generate electrical stimulation in a precise pattern.

The global neuromodulation market is segmented on the basis of technology, application, and region.  Based on technology, the market is segmented into internal  and external neuromodulation. Internal neuromodulation is further segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES). External neuromodulation is categorized into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES). The spinal cord stimulation (SCS) segment is expected to have the largest share of the global internal neuromodulation market in 2015. On the other hand, the transcutaneous electrical nerve stimulation (TENS) segment is expected to register the largest share of the global external neuromodulation market in 2015.

Based on application, the neuromodulation market is segmented into technology-wise applications such as spinal cord stimulation (chronic pain, failed back surgery, ischemia); deep brain stimulation (Parkinson's disease, tremor, depression, others), sacral nerve stimulation (urine incontinence, fecal incontinence), vagus nerve stimulation (epilepsy, others), gastric electrical stimulation (gastro paresis, obesity), transcutaneous electrical nerve stimulation (treatment resistant depression, others), and transcranial magnetic stimulation (depression, migraine headaches).

The key factors that are expected to spur the growth of this market include rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by players, and expanded target applications and new indications. Moreover, expansion in emerging economies is likely to create significant growth opportunities for players operating in the market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals are likely to pose as deterrents hampering market growth.

On the basis of region, this market is classified into North America, Europe, Asia-Pacific, and rest of the world (RoW).

Global Neuromodulation Market Size, by Region, 2015-2020

Neurostimulation Market

Note: Size of the bubble indicates market size ($Million) for respective markets in 2015

Source: International Neuromodulation Society, Neuromodulation Society of U.K. and Ireland (NSUKI), Neuromodulation Society of Australia & New Zealand, Canadian Neuromodulation Society, American Neuromodulation Society, North American Neuromodulation Society (NANS), Society of British Neurological Surgeons (SBNS), National Institute for Cardiovascular Outcomes Research (NICOR), Expert Interviews, and MarketsandMarkets Analysis

The global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020, to reach $6.20 Billion by 2020 from $3.65 Billion in 2015. The market is dominated by North America, followed by Europe, Asia-Pacific, and rest of the world (RoW). Asia-Pacific is expected to grow at the highest CAGR during the forecast period.

Some of the major players in the global market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel).

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
           2.1.1 Research Methodology Steps
           2.1.2 Secondary and Primary Research Methodology
                    2.1.2.1 Secondary Research
                    2.1.2.2 Primary Research
           2.1.3 Key Data From Primary Sources
           2.1.4 Key Insights From Primary Sources
                    2.1.4.1 Key Industry Insights
           2.1.5 Market Size Estimation Methodology
           2.1.6 Research Design
           2.1.7 Market Data Validation and Triangulation
           2.1.8 Assumptions for the Study

3 Executive Summary (Page No. - 32)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 38)
    4.1 Market Overview of Neuromodulation
    4.2 Global Neuromodulation Market, By Type
    4.3 Geographic Analysis of the Deep Brain Stimulation Market, By Application
    4.4 Internal Neuromodulation Market, By Modality
    4.5 Geographical Snapshot

5 Market Overview (Page No. - 43)
    5.1 Introduction
    5.2 Market Segmentation of Neuromodulation
    5.3 Market Dynamics of Neuromodulation
    5.1 Drivers
                    5.1.1.1 Rising Prevalence of Neurological Disorders to Spur Market Growth
                    5.1.1.2 Unprecedented Increase in the Aging Population to Fuel Market Growth
                    5.1.1.3 Strong Product Pipeline to Propel the Market
                    5.1.1.4 Expanded Target Applications and New Indications are Expected to Stimulate the Growth of Neuromodulation Devices
                    5.1.1.5 Investments and Funds – an Impetus for Market Growth
    5.2 Restraints
                    5.2.1.1 Unfavorable Reimbursement Scenario Hinders Market Growth
                    5.2.1.2 Lack of Trained Professionals Likely to Hamper Market Growth
    5.3 Opportunities
                    5.3.1.1 Expansion in Emerging Economies

6 Global Neuromodulation Market, By Technology (Page No. - 52)
    6.1 Introduction
    6.2 Internal Neuromodulation
           6.2.1 Spinal Cord Stimulation (SCS)
           6.2.2 Deep Brain Stimulation (DBS)
           6.2.3 Vagus Nerve Stimulation (VNS)
           6.2.4 Sacral Nerve Stimulation (SNS)
           6.2.5 Gastric Electrical Stimulation (GES)
    6.3 External Neuromodulation (Non-Invasive)
           6.3.1 Transcutaneous Electrical Nerve Stimulation (Tens)
           6.3.2 Transcranial Magnetic Stimulation (TMS)
           6.3.3 Respiratory Electrical Stimulation (RES)

7 Global Neuromodulation Market, By Application (Page No. - 77)
    7.1 Introduction
    7.2 Spinal Cord Stimulation (SCS) Market, By Application
           7.2.1 Failed Back Syndrome (FBSS)
           7.2.2 Chronic Pain
           7.2.3 Ischemia
    7.3 Deep Brain Stimulation (DBS) Market, By Application
           7.3.1 Parkinson’s Disease
           7.3.2 Tremor
           7.3.3 Depression
           7.3.4 Other Dbs Applications
    7.4 Sacral Nerve Stimulation Market, By Application
           7.4.1 Urine Incontinence
           7.4.2 Fecal Incontinence
    7.5 Vagus Nerve Stimulation Market, By Application
           7.5.1 Epilepsy
           7.5.2 Other Vns Applications
    7.6 Gastric Electrical Stimulation Market, By Application
           7.6.1 Gastroparesis
           7.6.2 Obesity
    7.7 Transcutaneous Electrical Nerve Stimulation Market, By Application
           7.7.1 Treatment Resistant Depression
           7.7.2 Other Tens Applications
    7.8 Repetitive Transcranial Magnetic Stimulation Market, By Application
           7.8.1 Depression
           7.8.2 Migraine Headache
    7.9 Respiratory Electrical Stimulation Market, By Application
           7.9.1 Spinal Cord Injury

8 Neuromodulation Market, By Region (Page No. - 93)
    8.1 Introduction
    8.2 North America
           8.2.1 U.S.
                    8.2.1.1 Rising Prevalence of Chronic Diseases In The U.S.
                    8.2.1.2 Increasing Aging Population In The U.S.
                    8.2.1.3 Increasing Lyme Disease Cases In The U.S.
                    8.2.1.4 Conferences & Annual Meetings To Increase Exposure of Neuromodulation
           8.2.2 Canada
                    8.2.2.1 Increasing Incidence of Lyme Disease In Canada
                    8.2.2.2 Increasing Incidences of Cancer And Diabetes
           8.2.3 Europe
                               8.2.3.1.1 Rapidly Aging Population In Europe
                               8.2.3.1.2 Conferences & Annual Meetings To Increase Exposure To Neuromodulation in the European Market
                    8.2.3.2 Germany
                               8.2.3.2.1 Rising Prevalence of Parkinson’s Disease In Germany
                    8.2.3.3 U.K.
                               8.2.3.3.1 Rising Prevalence of Diabetes In The U.K.
                               8.2.3.3.2 Rise In CVD Prevalence In The U.K.
                    8.2.3.4 France
                               8.2.3.4.1 Rising Incidences of Alzheimer's Disease And Dementia
                    8.2.3.5 Rest of Europe
                               8.2.3.5.1 High Diabetes Prevalence In Russia, Turkey, Poland, Romania, And Ukraine
           8.2.4 Asia-Pacific
                    8.2.4.1 Japan
                               8.2.4.1.1 Rising Adoption of Neurostimulation
                    8.2.4.2 China
                               8.2.4.2.1 High Diabetes Incidences And Rapidly Aging Population
                    8.2.4.3 India
                               8.2.4.3.1 Increasing Geriatric Population & High Diabetes Incidence
                               8.2.4.3.2 Conferences On Neuromodulation & Pain Management In India
                    8.2.4.4 Rest of Asia-Pacific (ROAPAC)
                               8.2.4.4.1 Increasing Prevalence of Parkinson’s Disease In Singapore
                               8.2.4.4.2 Conferences On Neuromodulation In Australia
           8.2.5 Rest of The World
                               8.2.5.1.1 Increasing Incidences of Cancer In Latin America
                               8.2.5.1.2 Rise In Aging Population & Prevalence of Diabetes

9 Competitive Landscape (Page No. - 134)
    9.1 Overview
    9.2 Market Share Analysis fo Neuromodulation, By Key Player
           9.2.1 Introduction
    9.3 Medtronic, Inc.
    9.4 Boston Scientific Corporation
    9.5 ST. Jude Medical, Inc.
    9.6 Competitive Scenario
           9.6.1 Market Development of Neuromodulation
           9.6.2 Agreements, Collaborations, Mergers, and Partnerships
           9.6.3 New Product Launches
           9.6.4 Acquisitions
           9.6.5 Expansion

10 Company Profiles (Page No. - 146)
     10.1 Introduction
     10.2 Medtronic, Inc.
             10.2.1 Business Overview
             10.2.2 Medtronic, Inc.: Company Snapshot
             10.2.3 Products & Services
             10.2.4 Recent Developments
             10.2.5 MnM View
     10.3 Boston Scientific Corporation
             10.3.1 Business Overview
             10.3.2 Boston Scientific Corporation: Company Snapshot
             10.3.3 Product Offerings
             10.3.4 Recent Developments
             10.3.5 MnM View
     10.4 ST. Jude Medical, Inc.
             10.4.1 Business Overview
             10.4.2 ST Jude Medical, Inc.: Company Snapshot
             10.4.3 Product Offerings:
             10.4.4 Recent Developments
             10.4.5 MnM View
     10.5 Cyberonics, Inc.
             10.5.1 Business Overview
             10.5.2 Cyberonics, Inc.: Company Snapshot
             10.5.3 Product Portfolio
             10.5.4 Recent Developments
     10.6 Nevro Corporation
             10.6.1 Business Overview
             10.6.2 Nevro Corporation: Company Snapshot
             10.6.3 Product Offerings
             10.6.4 Recent Developments
     10.7 Neurosigma, Inc.
             10.7.1 Business Overview
             10.7.2 Neurosigma, Inc.: Company Snapshot
             10.7.3 Product Offerings
             10.7.4 Recent Developments
     10.8 Neuropace, Inc.
             10.8.1 Business Overview
             10.8.2 Neuropace, Inc.: Company Snapshot
             10.8.3 Product Offerings
             10.8.4 Recent Developments
     10.9 Biocontrol Medical
             10.9.1 Business Overview
             10.9.2 Biocontrol Medical: Company Snapshot
             10.9.3 Product Offerings
             10.9.4 Recent Developments
     10.10 Synapse Biomedical, Inc.
             10.10.1 Business Overview
             10.10.2 Synapse Biomedical, Inc.: Company Snapshot
             10.10.3 Product Offerings
             10.10.4 Recent Developments
     10.11 Neuronetics, Inc.
     10.12 Business Overview
             10.12.1 Neuronetics, Inc.: Company Snapshot
             10.12.2 Product and Service Offerings
             10.12.3 Recent Developments

11 Appendix (Page No. - 172)
     11.1 Discussion Guide
     11.2 Company Developments (2012-2015)
             11.2.1 Medtronic, Inc.
             11.2.2 Boston Scientific Corporation
             11.2.3 ST Jude Medical, Inc.
             11.2.4 Neurosigma, Inc.
     11.3 Introducing RT: Real-Time Market Intelligence
     11.4 Available Customizations
     11.5 Related Reports

List of Tables (84 Tables)

Table 1 Increasing Incidence of Neurological Disorders is Propelling the Growth of the Global Neuromodulation Market
Table 2 Unfavourable Reimbursement Structure is Restraining the Growth of the Global Neuromodulation Market
Table 3 Expansion in Emerging Markets has a Huge Potential for Growth in the Global Neuromodulation Market
Table 4 Global Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 5 Internal Neuromodulation Market Size, By Region, 2013-2020 ($Million)
Table 6 Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 7 Internal Neuromodulation Market Size, By Modality, 2013-2020 (Units)
Table 8 Spinal Cord Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 9 Spinal Cord Stimulation Market Size, 2013-2020 (Units)
Table 10 Deep Brain Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 11 Deep Brain Stimulation Market Size, 2013-2020 (Units)
Table 12 Vagus Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 13 Vagus Nerve Stimulation Market Size, 2013-2020 (Units)
Table 14 Sacral Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 15 Sacral Nerve Stimulation Market Size, 2013-2020 (Units)
Table 16 Gastric Electrical Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 17 Gastric Electrical Stimulation Market Size, 2013-2020 (Units)
Table 18 External Neuromodulation Market Size, By Region, 2013-2020 ($Million)
Table 19 External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 20 External Neuromodulation Market Size, By Modality, 2013-2020 (Units)
Table 21 Transcutaneous Electrical Nerve Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 22 Gastric Electrical Stimulation Market Size, 2013-2020 (Units)
Table 23 Transcranial Magnetic Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 24 Transcranial Magnetic Stimulation Market Size, 2013-2020 (Units)
Table 25 Respiratory Electrical Stimulation Market Size, By Region, 2013-2020 ($Million)
Table 26 Respiratory Electrical Stimulation Market Size, 2013-2020 (Units)
Table 27 Global Spinal Cord Stimulation Market, By Application, 2013–2020 ($Million)
Table 28 Global Deep Brain Stimulation Market, By Application, 2013–2020 ($Million)
Table 29 Global Sacral Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 30 Global Vagus Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 31 Global Gastric Electrical Stimulation Market, By Application, 2013–2020 ($Million)
Table 32 Global Transcutaneous Electrical Nerve Stimulation Market, By Application, 2013–2020 ($Million)
Table 33 Global Transcranial Magnetic Stimulation Market, By Application, 2013–2020 ($Million)
Table 34 Neuromodulation Market Size, By Region, 2013-2020($Million)
Table 35 North America: Neuromodulation Market Size, By Country, 2013–2020 ($Million)
Table 36 North America: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 37 North America: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 38 North America: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 39 U.S.: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 40 U.S.: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 41 U.S.: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 42 Canada: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 43 Canada: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 44 Canada: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 45 Europe: Neuromodulation Market Size, By Country, 2013-2020 ($Million)
Table 46 Europe: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 47 Europe: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 48 Europe: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 49 Germany: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 50 Germany: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 51 Germany: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 52 U.K.: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 53 U.K.: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 54 U.K.: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 55 France: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 56 France: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 57 France: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 58 Rest of Europe: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 59 Rest of Europe: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 60 Rest of Europe: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 61 Asia-Pacific: Neuromodulation Market Size, By Country, 2013-2020 ($Million)
Table 62 Asia-Pacific: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 63 Asia-Pacific: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 64 Asia-Pacific: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 65 Japan: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 66 Japan: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 67 Japan: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 68 China: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 69 China: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 70 China: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 71 India: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 72 India: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 73 India: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 74 ROAPAC: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 75 ROAPAC: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 76 ROAPAC: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 77 Rest of the World: Neuromodulation Market Size, By Type, 2013-2020 ($Million)
Table 78 Rest of the World: Internal Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 79 Rest of the World: External Neuromodulation Market Size, By Modality, 2013-2020 ($Million)
Table 80 Recent Developments, 2012–2014
Table 81 Recent Developments, 2012–2014
Table 82 Recent Developments, 2012–2014
Table 83 Recent Developments, 2012–2014
Table 84 Recent Developments, 2012–2014

List of Figures (32 Figures)

Figure 1 Market Segmentation
Figure 2 Market Research Methodology Steps
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Internal Neuromodulation Segment to Witness the Highest CAGR of 11.4% From 2015 to 2020
Figure 8 Deep Brain Stimulation to Grow at the Highest CAGR of 14.2% During the Forecast Period
Figure 9 Transcutaneous Electrical Nerve Stimulation is Expected to Command the Largest Share in 2015
Figure 10 Parkinson’s Disease is Expected to Command the Largest Share in 2015
Figure 11 Asia-Pacific Slated to Witness the Highest Growth in the Neuromodulation Market During the Forecast Period
Figure 12 Attractive Opportunities in the Neuromodulation Market
Figure 13 Internal Modulation Technology to Witness the Highest Growth During the Forecast Period
Figure 14 North America to Dominate the Neuromodulation Market
Figure 15 Deep Brain Stimulation Segment to Witness Highest Growth Rate During the Forecast Period
Figure 16 Asia-Pacific to Witness Highest Growth Rate From 2015 to 2020
Figure 17 Global Neuromodulation Market, By Type
Figure 18 Internal Neuromodulation Segment to Grow at the Highest CAGR of 11.2% During the Forecast Period
Figure 19 Asia-Pacific to Grow at the Highest CAGR of 14.9% During the Forecast Period
Figure 20 Asia-Pacific to Grow at the Highest CAGR of 13.4% During the Forecast Period
Figure 21 Transcranial Magnetic Stimulation to Grow at the Highest CAGR During the Forecast Period
Figure 22 Global  Internal Neuromodulation  Market, By Application
Figure 23 Global  External Neuromodulation  Market, By Application
Figure 24 North America is Expected to Command the Largest Share of the Global Market in 2015
Figure 25 U.S. to Witness the Highest Growth in the Global Market in North America (2015)
Figure 26 Germany to Witness the Highest Growth in the Global Neuromodulation Market in Europe (2015)
Figure 27 Asia-Pacific, the Fastest-Growing Segment in the Global Market
Figure 28 RoW Expected to Grow at A CAGR of 13.3% During 2015 to 2020
Figure 29 Market Share Analysis of Neuromodulation, By Key Player, 2014
Figure 30 Neuromodulation Strategies Adopted By Key Players Over the Last Four Years (2012-2015)
Figure 31 Battle for Market Share of Neuromodulation: Market Develpoment was the Key Strategy
Figure 32 Neuromodulation Geographical Revenue Mix of Top Players


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 3571
Published ON
Jul, 2015
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Neuromodulation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved